BioCentury
ARTICLE | Company News

Helsinn, CJ sales and marketing update

October 1, 2012 7:00 AM UTC

Helsinn granted CJ's CJ CheilJedang subsidiary an exclusive license to distribute oral and IV forms of Netu-palo-FDC in South Korea to prevent chemotherapy-induced nausea and vomiting (CINV). Netu-pa...